Beta Bionics (BBNX) EBITDA Margin (2024 - 2026)
Beta Bionics' EBITDA Margin was -72.28% in Q3 2026, down 10.06 percentage points from -62.22% a year earlier but up 5.14 percentage points from the prior quarter.
Powered by 
Analysis
Beta Bionics (BBNX) EBITDA Margin (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Beta Bionics' EBITDA Margin was -70.40% through Sep 30, 2026, up 7.86 percentage points year-over-year; for FY2025, it came in at -69.91%, down 2.26 percentage points from FY2024.
- In earlier years, EBITDA Margin was -67.64% in FY2024 (+221.01 pp) and -288.65% in FY2023.
- Quarterly EBITDA Margin has moved between -109.16% (Q1 2025) and -48.44% (Q4 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last seven quarters, with an average year-over-year change of -1.46 percentage points.
- Per Business Quant data, BBNX's EBITDA Margin in the three quarters before Q3 2026 was -77.42% (Q2 2026), -85.37% (Q1 2026) and -48.44% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Beta Bionics | 898.08 Mn | 58.74 Mn | 20.33 Mn | -72.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -72.28% |
| Jun 30, 2026 | -77.42% |
| Mar 31, 2026 | -85.37% |
| Dec 31, 2025 | -48.44% |
| Sep 30, 2025 | -62.22% |
| Jun 30, 2025 | -87.52% |
| Mar 31, 2025 | -109.16% |
| Dec 31, 2024 | -62.41% |
| Sep 30, 2024 | -63.80% |
| Jun 30, 2024 | -76.33% |
| Mar 31, 2024 | -70.77% |
API Access
Beta Bionics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BBNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BBNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BBNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();